Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
暂无分享,去创建一个
[1] K. Chang,et al. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu , 1995, The Journal of experimental medicine.
[2] J. Gall,et al. Localization of the nucleolar protein NO38 in amphibian oocytes , 1992, The Journal of cell biology.
[3] R. Berger,et al. Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants. , 1992, Oncogene.
[4] W. Dinjens,et al. EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA , 1996, The Journal of pathology.
[5] D. Leprince,et al. Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression. , 1996, Biochemical and biophysical research communications.
[6] R Berger,et al. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). , 1991, Blood.
[7] M. Weitzman,et al. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. , 1996, Genes & development.
[8] P. Maslak,et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. , 1994, Blood.
[9] G. Fu,et al. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Ōmura,et al. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. , 1996, Cancer Research.
[11] Jacek Ostrowski,et al. Two distinct actions of retinoid-receptor ligands , 1996, Nature.
[12] F. Mitelman,et al. Molecular analysis of simple variant translocations in acute promyelocytic leukemia , 1994, Genes, chromosomes & cancer.
[13] C. Schindler,et al. Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action , 1997, Oncogene.
[14] R. Warrell,et al. Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis. , 1996, Blood.
[15] F. Berger,et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki‐1 lymphoma') , 1989, British journal of haematology.
[16] A. Toscani,et al. Arrest of spermatogenesis and defective breast development in mice lacking A-myb , 1997, Nature.
[17] T. Naoe,et al. Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: Sequence non‐specific recombination between the pml and rara genes within identical short stretches , 1995, Genes, chromosomes & cancer.
[18] Peirong Yang,et al. Analysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML(*) , 1996, The Journal of Biological Chemistry.
[19] E. Garattini,et al. Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia. , 1996, Leukemia & lymphoma.
[20] I. Weissman,et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Reeves,et al. Sodium butyrate inhibits histone deacetylation in cultured cells , 1978, Cell.
[22] M Alcalay,et al. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. , 1992, Oncogene.
[23] T. Barbui,et al. Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. , 1997, Blood.
[24] E. Gluckman,et al. PML is expressed in chronic graft-versus-host disease lesions , 1997, Bone Marrow Transplantation.
[25] P. Chambon,et al. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism , 1995, Molecular and cellular biology.
[26] K. Borden,et al. The promyelocytic leukemia protein PML has a pro‐apoptotic activity mediated through its RING domain , 1997, FEBS letters.
[27] E. Yeh,et al. Identification of Three Major Sentrinization Sites in PML* , 1998, The Journal of Biological Chemistry.
[28] E. Dmitrovsky,et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. McPherson,et al. MORTALITY IN ORAL CONTRACEPTIVE USERS , 1981, The Lancet.
[30] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.
[31] M. Lanotte,et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] M Kitagawa,et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 , 1993, Science.
[33] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[34] P. Sassone-Corsi. Transcriptional checkpoints determining the fate of male germ cells. , 1997, Cell.
[35] S. Horinouchi,et al. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[36] T. Barbui,et al. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. , 1994, Blood.
[37] W. Miller,et al. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. , 1997, Blood.
[38] S. Wolbach,et al. TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.
[39] M. Dundr,et al. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. , 1995, Journal of cell science.
[40] A. Dejean,et al. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] L. Szekely,et al. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies , 1996, Journal of virology.
[42] P. Chambon,et al. Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2). , 1995, Developmental biology.
[43] A. Zelent,et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Pelicci,et al. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein. , 1998, Blood.
[45] P. Chambon,et al. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. , 1993, The EMBO journal.
[46] R. Yamanaka,et al. A Novel Human CCAAT/Enhancer Binding Protein Gene, C/EBPϵ, Is Expressed in Cells of Lymphoid and Myeloid Lineages and Is Localized on Chromosome 14q11.2 Close to the T-Cell Receptor α/δ Locus , 1996 .
[47] A. Mahfoudi,et al. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] B. Alberts,et al. The Drosophila GAGA transcription factor is associated with specific regions of heterochromatin throughout the cell cycle. , 1994, The EMBO journal.
[49] P. Chambon,et al. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.
[50] D. Catovsky,et al. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. , 1994, Blood.
[51] E. Seto,et al. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. , 1994, The Journal of biological chemistry.
[52] S. Pittaluga,et al. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. , 1996, Blood.
[53] P. Fenaux,et al. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. , 1994, Leukemia.
[54] C. Van Sant,et al. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3 , 1997, Journal of virology.
[55] A. Yacoub,et al. Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity. , 1996, Nucleic acids research.
[56] D. Leprince,et al. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Correia,et al. Sedimentation analyses of the salt- and divalent metal ion-induced oligomerization of nucleolar protein B23. , 1996, Biochemistry.
[58] M. Privalsky,et al. Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6* , 1998, The Journal of Biological Chemistry.
[59] D. Grimwade,et al. Establishing the presence of the t( 15; 17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial , 1996, British journal of haematology.
[60] R. Everett,et al. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. , 1996, Virology.
[61] M. Montminy,et al. Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.
[62] D. Tenen,et al. Characterization of the myeloid-specific CD11b promoter. , 1992, Blood.
[63] D. Leprince,et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[64] D. Compton,et al. NuMA, a nuclear protein involved in mitosis and nuclear reformation. , 1994, Current opinion in cell biology.
[65] P. Chan. Cross-linkage of nucleophosmin in tumor cells by nitrogen mustard. , 1989, Cancer research.
[66] H. Busch,et al. Effects of luzopeptins on protein B23 translocation and ribosomal RNA synthesis in HeLa cells. , 1986, Cancer research.
[67] B. Yung,et al. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line , 1991, International journal of cancer.
[68] P. Brown,et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Wells,et al. Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia , 1997, Nature Genetics.
[70] L. Szekely,et al. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. , 1996, Experimental cell research.
[71] K. Tobal,et al. Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukaemia. , 1995, British journal of haematology.
[72] T. Naoe,et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. , 1996, Blood.
[73] P. Chambon,et al. Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. , 1996, The EMBO journal.
[74] H. Will,et al. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. , 1990, Journal of immunology.
[75] D. Moore,et al. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.
[76] S. Spiegel,et al. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody , 1988, The Journal of cell biology.
[77] J. Downing,et al. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. , 1994, The American journal of pathology.
[78] G. Fu,et al. Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Chang,et al. A single gene codes for two forms of rat nucleolar protein B23 mRNA. , 1989, The Journal of biological chemistry.
[80] E. Milgrom,et al. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. , 1995, Molecular endocrinology.
[81] M. Raffeld,et al. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up‐regulation in rat la fibroblasts , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[82] E. Dmitrovsky,et al. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. , 1995, Oncogene.
[83] Philippe Kastner,et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.
[84] M. Wu,et al. Evidence for the ability of nucleophosmin/B23 to bind ATP. , 1998, The Biochemical journal.
[85] E. Chan,et al. Autoantibodies in viral hepatitis-related hepatocellular carcinoma. , 1993, Intervirology.
[86] C. Murphy,et al. Is the sphere organelle/coiled body a universal nuclear component? , 1995, Developmental genetics.
[87] P. Chambon,et al. RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. , 1993, The EMBO journal.
[88] R. Everett,et al. Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures , 1995, Journal of virology.
[89] P. Martiat,et al. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. , 1994, Leukemia.
[90] Y. Li,et al. Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat , 1997, Journal of virology.
[91] D. Green,et al. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis , 1996, The Journal of experimental medicine.
[92] S. Brenner,et al. A conserved retinoic acid response element required for early expression of the homeobox gene Hoxb-1 , 1994, Nature.
[93] A. Saïb,et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. , 1995, Oncogene.
[94] Keisuke Toyama,et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 , 1996, Nature Genetics.
[95] A. Zelenetz,et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). , 1995, Blood.
[96] B. Brinkley,et al. Centrophilin: a novel mitotic spindle protein involved in microtubule nucleation , 1991, The Journal of cell biology.
[97] D. Livingston,et al. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Chang,et al. cDNA and deduced primary structure of rat protein B23, a nucleolar protein containing highly conserved sequences. , 1988, The Journal of biological chemistry.
[99] A. Zelent,et al. RaRα1/RARα2-PML mRNA expression in acute promyelocytic leukemia cells : A molecular and laboratory-clinical correlative study , 1997 .
[100] E. Fuchs,et al. The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy. , 1995, Journal of cell science.
[101] T. Ley,et al. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. , 1997, Blood.
[102] D. Treré,et al. Quantitative changes of the two major AgNOR proteins, nucleolin and protein B23, related to stimulation of rDNA transcription. , 1995, Experimental cell research.
[103] A. Martelli,et al. Association of nuclear matrix proteins with granular and threaded nuclear bodies in cell lines undergoing apoptosis. , 1997, Experimental cell research.
[104] E. Dmitrovsky,et al. Transgenic expression of PML/RARalpha impairs myelopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[105] S. Wölfl,et al. L7 protein is a coregulator of vitamin D receptor‐retinoid X receptor‐mediated transactivation , 1998, Journal of cellular biochemistry.
[106] R. Evans,et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein , 1994, Cell.
[107] P. Pandolfi,et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. , 1998, The New England journal of medicine.
[108] J. H. Lee,et al. Identification of highly expressed genes in metastasis‐suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display , 1997, International journal of cancer.
[109] R. Kuriyama,et al. Primary structure and microtubule-interacting domain of the SP-H antigen: a mitotic MAP located at the spindle pole and characterized as a homologous protein to NuMA. , 1993, Journal of cell science.
[110] H. de Thé,et al. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.
[111] Jeng-Shin Lee,et al. Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.
[112] C. Hsu,et al. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells , 1998, Oncogene.
[113] J. Licht,et al. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia , 1999, Oncogene.
[114] A. Dejean,et al. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. , 1998, Blood.
[115] A. Dejean,et al. Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.
[116] M. Ladanyi,et al. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral t‐cell lymphomas and lymphomas of uncertain lineage, including 12 Ki‐I positive lymphomas , 1990, Genes, chromosomes & cancer.
[117] M. Tallman,et al. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. , 1998, Blood.
[118] S. Brusilow,et al. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. , 1995, Blood.
[119] S. M. de la Monte,et al. Identification and Characterization of a Leukocyte-specific Component of the Nuclear Body* , 1996, The Journal of Biological Chemistry.
[120] S. Swerdlow,et al. RARA and PML gene rearrangements in acute promyelocytic leukemia with complex translocations and atypical features , 1994, Genes, chromosomes & cancer.
[121] E. Dmitrovsky,et al. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells. , 1998, Oncogene.
[122] R. Evans,et al. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[123] A. Dejean,et al. A retrovirus carrying the promyelocyte‐retinoic acid receptor PML‐RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. , 1996, The EMBO journal.
[124] R. Treisman,et al. The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.
[125] T. Barbui,et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. , 1995, Blood.
[126] P. Chambon,et al. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. , 1994, The Journal of biological chemistry.
[127] P. Freemont,et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. , 1997, Blood.
[128] A. Dejean,et al. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[129] Y. Y. Lu,et al. Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation. , 1996, The Biochemical journal.
[130] F. Ruscetti,et al. Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines , 1990 .
[131] T. Pozzan,et al. Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival , 1998, Oncogene.
[132] S. Korsmeyer,et al. Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.
[133] F. Mandelli,et al. Early Detection of Relapse by Prospective Reverse Transcriptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Leukemia Enrolled in the GIMEMA-AIEOP Multicenter “AIDA” Trial , 1998 .
[134] J. Licht,et al. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. , 1996, Oncogene.
[135] T. Naoe,et al. Toxic effects of arsenic (As3+) and other metal ions on acute promyelocytic leukemia cells. , 1997, International journal of hematology.
[136] D. Treré,et al. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[137] P. Freemont,et al. The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.
[138] J. Hershey,et al. The Translation Initiation Factor eIF3-p48 Subunit Is Encoded byint-6, a Site of Frequent Integration by the Mouse Mammary Tumor Virus Genome* , 1997, The Journal of Biological Chemistry.
[139] T. Niikura,et al. A novel interferon-inducible gene expressed during myeloid differentiation. , 1997, Blood cells, molecules & diseases.
[140] P. Wingfield,et al. Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. , 1997, Biochemistry.
[141] R. D. Hanson,et al. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. , 1990, The Journal of biological chemistry.
[142] G. Avvisati,et al. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells. , 1997, Blood.
[143] A. Zelent,et al. RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study. , 1997, Blood.
[144] D. Compton,et al. Primary structure of NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis , 1992, The Journal of cell biology.
[145] D. Seripa,et al. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. , 1994, Cancer research.
[146] T. Naoe,et al. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha. , 1996, Oncogene.
[147] U. Thorsteinsdóttir,et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. , 1995, Genes & development.
[148] H. Koeffler,et al. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. , 1982, The Journal of clinical investigation.
[149] S. Minucci,et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.
[150] K. Itoh,et al. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site , 1996, Molecular and cellular biology.
[151] I. Todorov,et al. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants. , 1997, European journal of cell biology.
[152] S. Whittingham,et al. The nucleotide sequence of a human cDNA encoding the highly conserved nucleolar phosphoprotein B23. , 1989, Biochemical and biophysical research communications.
[153] E. Tan,et al. Novel nucleolar antigens in autoimmune disease. , 1987, The Journal of rheumatology. Supplement.
[154] R. Evans,et al. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[155] A. Dejean,et al. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. , 1989, The EMBO journal.
[156] Tom Maniatis,et al. Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.
[157] F. M. Hack,et al. Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines. , 1992, The EMBO journal.
[158] J. Chang,et al. Structure of the gene for rat nucleolar protein B23. , 1990, The Journal of biological chemistry.
[159] L. Gudas,et al. Overexpression of the cellular retinoic acid binding protein-I (CRABP- I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells , 1991, The Journal of cell biology.
[160] S. Collins,et al. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[161] J. Lotem,et al. Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[162] R. Kuriyama,et al. Identification of a minus end-specific microtubule-associated protein located at the mitotic poles in cultured mammalian cells. , 1991, European journal of cell biology.
[163] P. Chambon,et al. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. , 1995, Nature.
[164] S. Ziegler,et al. Modulation of human G‐CSF receptor mRNA and protein in normal and leukemic myeloid cells by G‐CSF and retinoic acid , 1995, Journal of leukocyte biology.
[165] G. Avvisati,et al. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase. , 1996, Blood.
[166] H. Koeffler,et al. INHIBITION OF THE CLONAL GROWTH OF HUMAN MYELOID LEUKEMIA CELLS , 1982 .
[167] G. S. Johnson,et al. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. , 1985, The Journal of biological chemistry.
[168] H. de Thé,et al. Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. , 1995, Experimental cell research.
[169] D A Parry,et al. NuMA/centrophilin: sequence analysis of the coiled-coil rod domain. , 1994, Biophysical journal.
[170] W. Chan,et al. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. , 1995, Blood.
[171] J. Downing,et al. MLL fusion genes in the 11q23 acute leukemias. , 1996, Cancer treatment and research.
[172] A. Sugawara,et al. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. , 1998, Blood.
[173] K. Ohyashiki,et al. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. , 1997, Blood.
[174] T. Naoe,et al. Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4. , 1995, Leukemia.
[175] S. Waxman,et al. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. , 1999, Blood.
[176] T. Sternsdorf,et al. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). , 1996, European journal of biochemistry.
[177] P. Chan,et al. Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells. , 1995, Biochimica et biophysica acta.
[178] H. Busch,et al. Electrophoretic analysis of HeLa cell and human liver nucleolar proteins and antigens. , 1985, Cancer investigation.
[179] S. Collins,et al. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.
[180] T. Kouzarides,et al. Transcriptional repression by the promyelocytic leukemia protein, PML. , 1997, Experimental cell research.
[181] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[182] J. Darnell. STATs and gene regulation. , 1997, Science.
[183] H. Kamei. Reversible large-body formation from nuclear bodies upon amino acid(s) starvation in T24 cells. , 1996, Experimental cell research.
[184] V. Bardwell,et al. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT , 1998, Oncogene.
[185] J. Labbé,et al. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase , 1990, Cell.
[186] D. Pettijohn,et al. Redistribution of the nuclear mitotic apparatus protein (NuMA) during mitosis and nuclear assembly. Properties of purified NuMA protein. , 1986, Experimental cell research.
[187] F. Lo Coco,et al. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. , 1992, The EMBO journal.
[188] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[189] M. Pfahl,et al. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. , 1996, Blood.
[190] L. Gudas,et al. Retinoic Acid-responsive Enhancers Located 3′ of the Hox A and Hox B Homeobox Gene Clusters , 1997, The Journal of Biological Chemistry.
[191] J. Harborth,et al. Epitope mapping and direct visualization of the parallel, in‐register arrangement of the double‐stranded coiled‐coil in the NuMA protein. , 1995, The EMBO journal.
[192] C. Lehner,et al. Major nucleolar proteins shuttle between nucleus and cytoplasm , 1989, Cell.
[193] P. Pelicci,et al. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. , 1991, Oncogene.
[194] A. Reddi. Symbiosio of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage , 1994, Journal of cellular biochemistry.
[195] L. Szekely,et al. The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein , 1998, Molecular and Cellular Biology.
[196] M. Kamps,et al. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. , 1994, Oncogene.
[197] T. Schroer,et al. Opposing motor activities are required for the organization of the mammalian mitotic spindle pole , 1996, The Journal of cell biology.
[198] L. Caskey,et al. Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9* , 1997, The Journal of Biological Chemistry.
[199] L. Deaven,et al. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia , 1992, Molecular and cellular biology.
[200] K. Smetana,et al. Immunofluorescence studies on proteins B23 and C23 in nucleoli of human lymphocytes. , 1984, Experimental cell research.
[201] K. Chang,et al. The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter , 1998, Molecular and Cellular Biology.
[202] C. Bloomfield,et al. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[203] T. Stokke,et al. NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas. , 1997, Molecular pathology : MP.
[204] S. Korsmeyer,et al. Life, death and nuclear spots , 1998, Nature Genetics.
[205] K. Borden,et al. An Arenavirus RING (Zinc-Binding) Protein Binds the Oncoprotein Promyelocyte Leukemia Protein (PML) and Relocates PML Nuclear Bodies to the Cytoplasm , 1998, Journal of Virology.
[206] K. Ohyashiki,et al. Neutrophil Secondary-Granule Deficiency as a Hallmark of All-Trans Retinoic Acid–Induced Differentiation of Acute Promyelocytic Leukemia Cells , 1997 .
[207] A. Zelent,et al. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. , 1992, Oncogene.
[208] M. Hung,et al. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis , 1998, Oncogene.
[209] C. Tribioli,et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.
[210] R. Yamanaka,et al. A novel human CCAAT/enhancer binding protein gene, C/EBPepsilon, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor alpha/delta locus. , 1996, Genomics.
[211] C. Samuel,et al. Isolation and characterization of a molecular cDNA clone of a human mRNA from interferon-treated cells encoding nucleolar protein B23, numatrin. , 1989, Biochemical and biophysical research communications.
[212] R. Berger,et al. Breakpoint clusters of the PML gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the PML‐RARA gene in a patient with t(15;17) , 1993, Genes, chromosomes & cancer.
[213] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[214] H. Stunnenberg,et al. Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.
[215] C. Chomienne,et al. Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. , 1993, Leukemia.
[216] R. Marmorstein,et al. Overexpression, Purification, Characterization, and Crystallization of the BTB/POZ Domain from the PLZF Oncoprotein* , 1997, The Journal of Biological Chemistry.
[217] R. Evans,et al. A retinoic acid-triggered cascade of HOXB1 gene activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[218] T. Sternsdorf,et al. Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1 , 1997, The Journal of cell biology.
[219] A. Mauger,et al. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1). , 1985, Biochemical pharmacology.
[220] S. Pileri,et al. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. , 1995, Blood.
[221] K. Pulford,et al. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.
[222] C. Tribioli,et al. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[223] P. Papenhausen,et al. Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid. , 1989, Leukemia.
[224] A. Pardee,et al. Recent advances in differential display. , 1995, Current opinion in immunology.
[225] N. Kamada,et al. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. , 1996, Blood.
[226] P. Pelicci,et al. Acute promyelocytic leukemia: from genetics to treatment. , 1994 .
[227] R. Krumlauf,et al. In vitro and transgenic analysis of a human HOXD4 retinoid-responsive enhancer. , 1996, Development.
[228] J. Licht,et al. Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[229] T. Taniguchi,et al. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity , 1997, Oncogene.
[230] D. Pettijohn,et al. Specific attachment of nuclear-mitotic apparatus protein to metaphase chromosomes and mitotic spindle poles: possible function in nuclear reassembly. , 1983, Journal of molecular biology.
[231] P. Chambon,et al. Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[232] H. Satoh,et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. , 1994, Oncogene.
[233] M. Ptashne. How eukaryotic transcriptional activators work , 1988, Nature.
[234] D. Compton,et al. NuMA is required for the proper completion of mitosis , 1993, The Journal of cell biology.
[235] K. Umesono,et al. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[236] F. Chang,et al. Dipyridamole enhancement of doxorubicin‐induced translocation of nucleophosmin and inhibition of cell growth in HL‐60 cells , 1991, International journal of cancer.
[237] E. Dmitrovsky,et al. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A , 1999, Oncogene.
[238] C. Glass,et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[239] Yi-Ping Li,et al. C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. , 1996, European journal of biochemistry.
[240] M. Andreeff,et al. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. , 1993, Cancer research.
[241] P. Chambon. A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[242] H. de Thé,et al. Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein , 1998, Journal of Virology.
[243] P. Freemont,et al. Does this have a familiar RING? , 1996, Trends in biochemical sciences.
[244] C. Wu,et al. Nuclear mitotic apparatus protein (NuMA): spindle association, nuclear targeting and differential subcellular localization of various NuMA isoforms. , 1994, Journal of cell science.
[245] Z. Wang,et al. All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases. , 1987, Chinese medical journal.
[246] D. Hernandez-Verdun. The nucleolar organizer regions , 1983 .
[247] A. Zelent,et al. Acute promyelocytic leukaemia associated PLZF protein interacts with the retinoblastoma tumour suppressor gene product. , 1998 .
[248] C. Peschle,et al. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. , 1996, The EMBO journal.
[249] T. Hsieh,et al. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells. , 1996, Biochemical and biophysical research communications.
[250] P. Tiollais,et al. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. , 1997, Oncogene.
[251] F. Mandelli,et al. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. , 1998, Blood.
[252] K. Kolibaba,et al. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. , 1994, Blood.
[253] P. Chambon,et al. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor. , 1995, Protein expression and purification.
[254] E. Schiavone,et al. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. , 1994, Leukemia.
[255] C. Pabo,et al. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. , 1993, Science.
[256] Chi-Wai Wong,et al. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.
[257] D. Compton,et al. Binding of matrix attachment regions to lamin polymers involves single-stranded regions and the minor groove , 1994, Molecular and cellular biology.
[258] J. Licht,et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[259] P. Freemont,et al. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. , 1991, Science.
[260] A. Zelent,et al. Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.
[261] K. Weber,et al. Cleavage of the nuclear matrix protein NuMA during apoptosis. , 1997, Experimental cell research.
[262] E. Dmitrovsky,et al. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells. , 1998, Blood.
[263] Christine Chomienne,et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.
[264] F. Hucho,et al. Nuclear substrates of protein kinase C. , 1992, European journal of biochemistry.
[265] M. Takemura,et al. Stimulation of Calf Thymus DNA Polymerase α Activity by Nucleolar Protein B23 , 1994 .
[266] S. Yonehara,et al. Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis , 1998, The Journal of experimental medicine.
[267] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[268] S. Minucci,et al. The histone acetylase PCAF is a nuclear receptor coactivator. , 1998, Genes & development.
[269] P. Freemont. The RING finger. A novel protein sequence motif related to the zinc finger. , 1993, Annals of the New York Academy of Sciences.
[270] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[271] U. Testa,et al. HOXB gene expression and function in differentiating purified hematopoietic progenitors. , 1995, Stem cells.
[272] R. Berger,et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. , 1993, The Journal of clinical investigation.
[273] R. Manfredini,et al. All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. , 1995, Experimental hematology.
[274] Qing-Rong Liu,et al. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.
[275] K. Ahmed,et al. Role of Protein Phosphorylation in Post-translational Regulation of Protein B23 during Programmed Cell Death in the Prostate Gland (*) , 1995, The Journal of Biological Chemistry.
[276] R. Evans,et al. The PML nuclear compartment and cancer. , 1996, Biochimica et biophysica acta.
[277] T. Sternsdorf,et al. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis , 1997, Hepatology.
[278] S. Pileri,et al. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. , 1996, The American journal of pathology.
[279] J. Sobczak-Thépot,et al. The PML growth-suppressor has an altered expression in human oncogenesis. , 1995, Oncogene.
[280] B. Brinkley,et al. Nuclear matrix proteins as structural and functional components of the mitotic apparatus. , 1995, International review of cytology.
[281] E. Tan,et al. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. , 1992, The American journal of pathology.
[282] Andrew J. Bannister,et al. The CBP co-activator is a histone acetyltransferase , 1996, Nature.
[283] S. Kaufmann,et al. Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[284] Y. Qi,et al. Quantitation of the nucleophosmin/B23-translocation using imaging analysis. , 1996, Cancer letters.
[285] B. Yung,et al. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells. , 1990, Cancer research.
[286] M. Snyder,et al. The nuclear-mitotic apparatus protein is important in the establishment and maintenance of the bipolar mitotic spindle apparatus. , 1992, Molecular biology of the cell.
[287] R. Jessberger,et al. A B-cell-specific DNA Recombination Complex* , 1998, The Journal of Biological Chemistry.
[288] J. Downing,et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. , 1995, Blood.
[289] A. Vaheri,et al. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[290] C. Wu,et al. Nuclear proteins of the bovine esophageal epithelium. II. The NuMA gene gives rise to multiple mRNAs and gene products reactive with monoclonal antibody W1. , 1993, Journal of cell science.
[291] P. Tempst,et al. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells. , 1996, Blood.
[292] P. Fenaux,et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. , 1994, Blood.
[293] P. Pandolfi,et al. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. , 1995, Oncogene.
[294] I. Hay,et al. Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. , 1990, Biochimica et biophysica acta.
[295] P. Pandolfi,et al. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. , 1998, Journal of the National Cancer Institute.
[296] S. Corey,et al. Differentiation of t(5;17) variant acute promyelocytic leukemic blasts by all-trans retinoic acid , 1997, Leukemia.
[297] P. Pelicci,et al. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. , 1993, Blood.
[298] X. Zhang,et al. A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene , 1995, Molecular and cellular biology.
[299] Z. Xie,et al. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region. , 1997, Nucleic acids research.
[300] K. Ramyar,et al. A Complex of NuMA and Cytoplasmic Dynein Is Essential for Mitotic Spindle Assembly , 1996, Cell.
[301] R S Chaganti,et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[302] R. Evans,et al. A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.
[303] P. Fenaux,et al. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. , 1993, Blood.
[304] P. Freemont,et al. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. , 1996, Oncogene.
[305] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[306] M. Tallman. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. , 1996, Leukemia.
[307] X. Le,et al. The biologic function of PML and its role in acute promyelocytic leukemia. , 1996, Leukemia & lymphoma.
[308] E. Dmitrovsky,et al. Targeting of PML/RAR Is Lethal to Retinoic Acid–Resistant Promyelocytic Leukemia Cells , 1998 .
[309] R. Ochs,et al. Nuclear bodies (NBs): a newly "rediscovered" organelle. , 1992, Experimental cell research.
[310] T. Barbui,et al. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. , 1998, Blood.
[311] N. Ringertz,et al. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[312] S. Raimondi,et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.
[313] H. Koeffler,et al. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. , 1994, Blood.
[314] T. Sternsdorf,et al. Cellular Localization, Expression, and Structure of the Nuclear Dot Protein 52 , 1997, The Journal of cell biology.
[315] D. Scheinberg,et al. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. , 1997, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.
[316] E. Boncinelli,et al. Coordinate regulation of HOX genes in human hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[317] C. Niu,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. , 1997, Blood.
[318] S. Mader,et al. The promoter of the H1zero histone gene contains a DNA element bound by retinoic acid receptors. , 1994, Journal of molecular biology.
[319] J. Licht,et al. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient , 1999, Oncogene.
[320] S. Waxman,et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. , 1993, Blood.
[321] P. Pelicci,et al. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[322] A. Philpott,et al. The role of nucleoplasmin in chromatin assembly and disassembly. , 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[323] P. Chambon,et al. Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. , 1997, Genes & development.
[324] G. Maul,et al. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment , 1995, The Journal of cell biology.
[325] A. Dejean,et al. Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. , 1996, Experimental hematology.
[326] R. Warrell,et al. The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.
[327] R. Berezney,et al. The nuclear matrix: a structural milieu for genomic function. , 1995, International review of cytology.
[328] M Hubank,et al. Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.
[329] R. Berger,et al. Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients. , 1993, Leukemia.
[330] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[331] D. Dhumeaux,et al. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. , 1996, Experimental cell research.
[332] R. Moyzis,et al. UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. , 1996, Genomics.
[333] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[334] T. Yasuda,et al. Identification and characterization of a nuclear scaffold protein that binds the matrix attachment region DNA. , 1993, The Journal of biological chemistry.
[335] T. Martin,et al. The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23. , 1995, Experimental cell research.
[336] P. Freemont,et al. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[337] S. Collins,et al. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. , 1994, Genes & development.
[338] J. Lehmann,et al. RAR gamma 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites , 1992, Molecular and cellular biology.
[339] P. Pelicci,et al. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies , 1998, Oncogene.
[340] R. Janknecht,et al. Transcription. A growing coactivator network. , 1996, Nature.
[341] K. Weber,et al. Ability to organize microtubules in taxol-treated mitotic PtK2 cells goes with the SPN antigen and not with the centrosome. , 1992, Journal of cell science.
[342] J. Harborth,et al. Microinjection of a monoclonal antibody against SPN antigen, now identified by peptide sequences as the NuMA protein, induces micronuclei in PtK2 cells. , 1993, Journal of cell science.
[343] L. Staudt,et al. Transcriptional repression by the proto-oncogene BCL-6. , 1996, Oncogene.
[344] F. Bischoff,et al. Isolation of human NuMA protein , 1994, FEBS letters.
[345] B. Plachter,et al. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. , 1996, Experimental cell research.
[346] A. Dejean,et al. The acute promyelocytic leukemia PML-RARα protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice , 1997, Oncogene.
[347] T. Enver,et al. Differential expression of retinoid receptors during multilineage differentiation of haemopoietic progenitor cells-role of the RAR alpha 2 isoform in normal granulopoiesis and leukaemia. , 1997 .
[348] S. Goueli,et al. Androgenic regulation of the expression and phosphorylation of prostatic nucleolar protein B23. , 1993, Cellular & molecular biology research.
[349] K. Borden,et al. Two RING Finger Proteins, the Oncoprotein PML and the Arenavirus Z Protein, Colocalize with the Nuclear Fraction of the Ribosomal P Proteins , 1998, Journal of Virology.
[350] K. Weber,et al. A 210 kDa nuclear matrix protein is a functional part of the mitotic spindle; a microinjection study using SPN monoclonal antibodies. , 1991, The EMBO journal.
[351] M. Lanotte,et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells. , 1998, Blood.
[352] L. Gudas,et al. Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox-1.6 , 1992, Mechanisms of Development.
[353] T. Barbui,et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia , 1992, The Lancet.
[354] M. Olson,et al. Phosphorylation of acid-soluble nucleolar proteins of Novikoff hepatoma ascites cells in vivo. , 1974, The Journal of biological chemistry.
[355] P. Tiollais,et al. The RARα-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain , 1997, Oncogene.
[356] Dunn Jl,et al. Analysis of the T1u , 1995 .
[357] P. Walker,et al. Unique behaviour of NuMA during heat-induced apoptosis of lymphocytes. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[358] A. Feller,et al. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? , 1995, The Lancet.
[359] L. Gudas. Retinoids and vertebrate development. , 1994, The Journal of biological chemistry.
[360] P. Low,et al. Signal transduction between red cells and other blood cells , 1995 .
[361] R. Rousset,et al. Exclusion of Int-6 from PML Nuclear Bodies by Binding to the HTLV-I Tax Oncoprotein , 1996, Science.
[362] L. Mejia,et al. Hematopoietic studies in vitamin A deficiency. , 1978, The American journal of clinical nutrition.
[363] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[364] A. Chumakov,et al. Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). , 1997, Blood.
[365] T. Arakawa,et al. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system , 1997, Oncogene.
[366] E. Estey,et al. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction. , 1992, Blood.
[367] H. Satoh,et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. , 1995, Blood.
[368] A. Simeone,et al. Developmental analysis of murine Promyelocyte Leukemia Zinc Finger (PLZF) gene expression: implications for the neuromeric model of the forebrain organization , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[369] F. Birg,et al. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes. , 1995, Blood.
[370] F. Birg,et al. Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia , 1995, Genes, chromosomes & cancer.
[371] P. Fenaux,et al. Differentiation therapy for acute promyelocytic leukemia. , 1997, The New England journal of medicine.
[372] M. Carrington,et al. A distinct cyclin A is expressed in germ cells in the mouse. , 1996, Development.
[373] R. Krumlauf. Hox genes in vertebrate development , 1994, Cell.
[374] D. Compton,et al. Phosphorylation regulates the assembly of NuMA in a mammalian mitotic extract. , 1997, Journal of cell science.
[375] M. Thelen,et al. Caspase‐mediated proteolysis during apoptosis: insights from apoptotic neutrophils , 1998, FEBS letters.
[376] H. Frierson,et al. Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. , 1995, The American journal of pathology.
[377] R. Everett,et al. A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.
[378] J. Lawrence,et al. Assignment of the nuclear mitotic apparatus protein NuMA gene to human chromosome 11q13. , 1993, Genomics.
[379] B. Howard,et al. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.
[380] Myriam Alcalay,et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.
[381] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[382] K. Jensen,et al. The Interferon (IFN)-stimulated Gene Sp100 Promoter Contains an IFN-γ Activation Site and an Imperfect IFN-stimulated Response Element Which Mediate Type I IFN Inducibility* , 1996, The Journal of Biological Chemistry.
[383] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[384] R. Berger,et al. JEM-1, a novel gene encoding a leucine-zipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukaemia , 1997, Oncogene.
[385] A. Zelent,et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. , 1998, Blood.
[386] X. Le,et al. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. , 1997, Carcinogenesis.
[387] M. Pazin,et al. What's Up and Down with Histone Deacetylation and Transcription? , 1997, Cell.
[388] M. Snyder,et al. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus , 1992, The Journal of cell biology.
[389] K. Weinberg,et al. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. , 1997, Blood.
[390] Min Yu,et al. Constitutive Expression of the Promyelocytic Leukemia–Associated Oncogene PML-RARα in TF1 Cells: Isoform-Specific and Retinoic Acid–Dependent Effects on Growth, bcl-2 Expression, and Apoptosis , 1998 .
[391] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[392] L. Hillestad,et al. Acute promyelocytic leukemia. , 2009 .
[393] D. Tenen,et al. CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[394] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[395] I. Weissman,et al. Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. , 1992, Blood.
[396] W. Miller. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features. , 1996, Cancer investigation.
[397] A. Iavarone,et al. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. , 1996, The Journal of biological chemistry.
[398] M. Lanotte,et al. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. , 1996, Oncogene.
[399] R. Cook,et al. Amino acid sequence of a specific antigenic peptide of protein B23. , 1986, The Journal of biological chemistry.
[400] D. Compton,et al. Mutation of the predicted p34cdc2 phosphorylation sites in NuMA impair the assembly of the mitotic spindle and block mitosis. , 1995, Journal of cell science.
[401] P. Randazzo,et al. In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. , 1991, Experimental Cell Research.
[402] J. Rowley,et al. 15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA , 1977, The Lancet.
[403] P. Pelicci,et al. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. , 1996, Blood.
[404] K. Pulford,et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.
[405] M. Frasch,et al. Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila. , 1995, Development.
[406] P. Chambon,et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. , 1992, The EMBO journal.
[407] J. Herrera,et al. Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. , 1995, Biochemistry.
[408] R. Krumlauf,et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. , 1995, Blood.
[409] R. Pine,et al. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. , 1996, Blood.
[410] K. Weinberg,et al. A Novel, Myeloid Transcription Factor, C/EBPε, Is Upregulated During Granulocytic, But Not Monocytic, Differentiation , 1997 .
[411] E. Dmitrovsky,et al. Targeting the PML/RARα translocation product triggers apoptosis in promyelocytic leukemia cells , 1998, Oncogene.
[412] Christine Chomienne,et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.
[413] S. Pileri,et al. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. , 1994, Cancer research.
[414] D. Pettijohn,et al. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: Distribution in a human/hamster hybrid cell , 1980, Cell.
[415] D. Hernandez-Verdun,et al. Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. , 1997, Cytometry.
[416] S. Nishikawa,et al. Overexpression of retinoic acid receptor alpha suppresses myeloid cell differentiation at the promyelocyte stage. , 1995, Oncogene.
[417] J. Bennett,et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. , 1995, Blood.
[418] E. Yu,et al. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress , 1995, Journal of cellular biochemistry.
[419] G. Lozano,et al. PML, a growth suppressor disrupted in acute promyelocytic leukemia , 1994, Molecular and cellular biology.
[420] C. Peschle,et al. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling , 1997, Molecular and cellular biology.
[421] M. Pfahl. Nuclear receptor/AP-1 interaction. , 1993, Endocrine reviews.
[422] E. Jaffe,et al. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. , 1995, Blood.
[423] P. Chan,et al. The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. , 1990, The Biochemical journal.
[424] D. Levy,et al. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation , 1998, Nature.
[425] A. Vaheri,et al. Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors. , 1994, Blood.
[426] S. Collins,et al. E3, a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha. , 1996, Blood.
[427] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.
[428] M. Olson,et al. Interaction of nucleolar phosphoprotein B23 with nucleic acids. , 1989, Biochemistry.
[429] M. Yu,et al. Constitutive expression of the promyelocytic leukemia-associated oncogene PML-RARalpha in TF1 cells: isoform-specific and retinoic acid-dependent effects on growth, bcl-2 expression, and apoptosis. , 1998, Blood.
[430] C. Peschle,et al. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. , 1998, The Journal of clinical investigation.
[431] P. Chambon,et al. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors , 1992, Cell.
[432] H. Will,et al. Autoantibodies Against “Nuclear Dots” in Primary Biliary Cirrhosis , 1997, Seminars in liver disease.
[433] T. Hunter,et al. A growing coactivator network , 1996, Nature.
[434] K. Umesono,et al. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. , 1996, Molecular endocrinology.
[435] H. de Thé,et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[436] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[437] T. Kouzarides,et al. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein , 1998, Oncogene.
[438] M. James,et al. A high-resolution STS, EST, and gene-based physical map of the hereditary paraganglioma region on chromosome 11q23. , 1997, Genomics.
[439] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[440] I. Weissman,et al. A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .
[441] P. Fenaux,et al. Biology and treatment of acute promyelocytic leukemia. , 1996, Current opinion in oncology.
[442] C. Vidair,et al. Phosphorylation of NUMA occurs during nuclear breakdown and not mitotic spindle assembly. , 1995, Journal of cell science.
[443] A. Dejean,et al. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia , 1997 .
[444] P. Fenaux,et al. Retinoic Acid Syndrome , 1998, Drug safety.
[445] Zi X. Chen,et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. , 1991, Blood.
[446] T. Rabbitts,et al. An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.
[447] F. Melchior,et al. A Small Ubiquitin-Related Polypeptide Involved in Targeting RanGAP1 to Nuclear Pore Complex Protein RanBP2 , 1997, Cell.
[448] R. Kriwacki,et al. Repression of TFIIH Transcriptional Activity and TFIIH-Associated cdk7 Kinase Activity at Mitosis , 1998, Molecular and Cellular Biology.
[449] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[450] P. Freemont,et al. A novel zinc finger coiled-coil domain in a family of nuclear proteins. , 1992, Trends in biochemical sciences.
[451] W. Huang,et al. Molecular study on the chromosome 15 breakpoints in the translocation t(15; 17) in acute promyelocytic leukemia (APL). , 1993, Science in China. Series B, Chemistry, life sciences & earth sciences.
[452] M. Takemura,et al. Stimulation of calf thymus DNA polymerase alpha activity by nucleolar protein B23. , 1994, Biochemical and biophysical research communications.
[453] B. Rollins,et al. Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. , 1994, Blood.
[454] G. Hayward,et al. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells , 1997, Journal of virology.
[455] R. Berger,et al. Rearrangements of the RARA and PML genes in a cytogenetic variant of acute promyelocytic leukemia , 1993, Genes, chromosomes & cancer.
[456] T. Naoe,et al. Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). , 1995, Leukemia.
[457] P. Chambon,et al. The Putative Cofactor TIF1α Is a Protein Kinase That Is Hyperphosphorylated upon Interaction with Liganded Nuclear Receptors* , 1998, The Journal of Biological Chemistry.
[458] C. Glass,et al. Regulation of gene expression by retinoic acid receptors. , 1991, DNA and cell biology.
[459] A. Merdes,et al. The role of NuMA in the interphase nucleus. , 1998, Journal of cell science.
[460] Steven M. Lipkin,et al. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors , 1991, Cell.
[461] A. Fornace,et al. Genotoxic‐Stress‐Response Genes and Growth‐Arrest Genes , 1992, Annals of the New York Academy of Sciences.
[462] M. Olson,et al. The nucleic acid binding activity of nucleolar protein B23.1 resides in its carboxyl-terminal end. , 1994, The Journal of biological chemistry.
[463] M. Privalsky,et al. Transcriptional Repression by the SMRT-mSin3 Corepressor: Multiple Interactions, Multiple Mechanisms, and a Potential Role for TFIIB , 1998, Molecular and Cellular Biology.
[464] P G Pelicci,et al. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. , 1992, Cancer research.
[465] H. de Thé,et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.
[466] J M Davies,et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[467] D. Wolgemuth,et al. The developmentally restricted pattern of expression in the male germ line of a murine cyclin A, cyclin A2, suggests roles in both mitotic and meiotic cell cycles. , 1996, Developmental biology.
[468] D. Compton,et al. NuMA assembles into an extensive filamentous structure when expressed in the cell cytoplasm. , 1996, Journal of cell science.
[469] H. Busch,et al. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. , 1985, Biochimica et biophysica acta.
[470] S. Inoue,et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.
[471] M. Fagioli,et al. The molecular genetics of acute promyelocytic leukemia. , 1993, Blood reviews.
[472] J. Basilion,et al. Identification and Characterization of a Versatile Retinoid Response Element (Retinoic Acid Receptor Response Element-Retinoid X Receptor Response Element) in the Mouse Tissue Transglutaminase Gene Promoter (*) , 1996, The Journal of Biological Chemistry.
[473] C. Sherr. Cancer Cell Cycles , 1996, Science.
[474] E. Macintyre,et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. , 1995, Blood.
[475] S. Collins. Acute promyelocytic leukemia: relieving repression induces remission. , 1998, Blood.
[476] N. Feuerstein. Phosphorylation of numatrin and other nuclear proteins by cdc2 containing CTD kinase cdc2/p58. , 1991, The Journal of biological chemistry.
[477] P. Chan,et al. Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein. , 1991, European journal of biochemistry.
[478] L. Nagy,et al. Retinoic acid induction of the tissue transglutaminase promoter is mediated by a novel response element , 1996, Molecular and Cellular Endocrinology.
[479] L. Degos. Differentiation therapy of leukemia. , 1994, Leukemia & lymphoma.
[480] J. Licht,et al. The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.
[481] K. Kamiya,et al. Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. , 1993, Nucleic acids research.
[482] E. Yeh,et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. , 1996, Journal of immunology.
[483] J. Licht,et al. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. , 1994, Blood.
[484] C. Peschle,et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. , 1998, Journal of the National Cancer Institute.
[485] H. van der Voort,et al. UvA-DARE (Digital Academic Repository) PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components , 2002 .
[486] A. Wolffe,et al. Histone acetyltransferases in control. , 1997, Current biology : CB.
[487] M. Aldrich,et al. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells. , 1987, Cancer research.
[488] S. Collins,et al. Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .
[489] K. Fung,et al. Effects of hyperthermia on the nucleolar proteins in tumour cells. , 1993, Cancer letters.
[490] R. Evans,et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. , 1992, Genes & development.
[491] N. Feuerstein,et al. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. , 1988, The Journal of biological chemistry.
[492] N. Stuurman,et al. The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.
[493] J. Herrera,et al. The ribonuclease activity of nucleolar protein B23. , 1995, Nucleic acids research.
[494] C. Glackin,et al. Absence of the t(2;5) in Hodgkin's disease. , 1995, Blood.
[495] Takuro Nakamura,et al. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.
[496] P. Chambon,et al. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. , 1994, The EMBO journal.
[497] P. Chambon,et al. SUG1, a Putative Transcriptional Mediator and Subunit of the PA700 Proteasome Regulatory Complex, Is a DNA Helicase* , 1997, The Journal of Biological Chemistry.
[498] P. Pelicci,et al. The acute promyelocytic leukemia-specific PML/RAR alpha fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells. , 1995, Leukemia.
[499] K. Umesono,et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.
[500] R. Krumlauf,et al. Retinoids and Hox genes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[501] J. Rowley,et al. LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. , 1996, Genomics.
[502] H. Hsu,et al. Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis. , 1996, Journal of cell science.
[503] S. Berget,et al. Nuclear-mitotic apparatus protein: a structural protein interface between the nucleoskeleton and RNA splicing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[504] A. Deblasio,et al. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. , 1996, Blood.
[505] S. Corey,et al. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.
[506] A. Dejean,et al. PML nuclear bodies are general targets for inflammation and cell proliferation. , 1995, Cancer research.
[507] P. Freemont,et al. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. , 1998, Journal of cell science.
[508] Rowley Jd. Rearrangements involving chromosome band 11Q23 in acute leukaemia. , 1993 .
[509] P. Chambon,et al. Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells. , 1996, Gene.
[510] P. Chan. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). , 1992, Experimental cell research.
[511] P. Pandolfi,et al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[512] T. Taniguchi,et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.
[513] A. Dejean,et al. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[514] D. Lowy,et al. The Papillomavirus Minor Capsid Protein, L2, Induces Localization of the Major Capsid Protein, L1, and the Viral Transcription/Replication Protein, E2, to PML Oncogenic Domains , 1998, Journal of Virology.
[515] P. Pelicci,et al. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. , 1996, Blood.
[516] M. Pearson,et al. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[517] B. Howard,et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.
[518] F. M. Hack,et al. Expression of retinoic acid receptor alpha mRNA in human leukemia cells. , 1989, Blood.
[519] B. Brinkley,et al. Localization of NuMA protein isoforms in the nuclear matrix of mammalian cells. , 1994, Cell motility and the cytoskeleton.
[520] K. Tobal,et al. Persistence of RARa‐PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long‐term remission of acute promyelocytic leukaemia , 1995 .
[521] S. Kamel‐Reid,et al. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation. , 1996, Leukemia.
[522] G. Privé,et al. Crystal structure of the BTB domain from PLZF. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[523] E. Dmitrovsky,et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. , 1993, Blood.
[524] Wei-Wei Zhang,et al. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. , 1997, Biochemical and biophysical research communications.
[525] B. Valdez,et al. Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. , 1994, The Journal of biological chemistry.
[526] P. Pandolfi,et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. , 1998, Blood.
[527] R. Warrell,et al. Acute promyelocytic leukemia. , 1993, The New England journal of medicine.
[528] K. Umesono,et al. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.
[529] J. Workman,et al. A histone‐binding protein, nucleoplasmin, stimulates transcription factor binding to nucleosomes and factor‐induced nucleosome disassembly. , 1994, The EMBO journal.
[530] A. Levin,et al. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. , 1996, Blood.
[531] C. Tribioli,et al. Acute leukemia with promyelocytic features in PML/RARα transgenic mice , 1997 .
[532] J. Licht,et al. Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein* , 1997, The Journal of Biological Chemistry.
[533] A. Dejean,et al. Molecular Cloning of a New Interferon-induced PML Nuclear Body-associated Protein* , 1997, The Journal of Biological Chemistry.
[534] K. Robertson,et al. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells , 1992, Molecular and cellular biology.
[535] P. Pandolfi,et al. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. , 1997, Blood.
[536] A. Dejean,et al. The t(15;17) translocation in acute promyelocytic leukemia. , 1994, Pathologie-biologie.
[537] M. Andreeff,et al. The PML gene encodes a phosphoprotein associated with the nuclear matrix. , 1995, Blood.
[538] K. Horwitz,et al. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. , 1997, Molecular endocrinology.
[539] D. Compton,et al. NuMA is required for the organization of microtubules into aster-like mitotic arrays , 1995, The Journal of cell biology.
[540] R. Stone,et al. All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells. , 1993, Leukemia.
[541] J. Locker,et al. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features. , 1994, Leukemia.
[542] J J Mond,et al. "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. , 1987, The Journal of biological chemistry.
[543] J. M. Adams,et al. Enforced expression of Hlx homeobox gene prompts myeloid cell maturation and altered adherence properties of T cells. , 1993, Blood.
[544] P. Freemont,et al. Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies. , 1997, Journal of cell science.
[545] A. Dejean,et al. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix- associated PML bodies , 1995, The Journal of cell biology.
[546] L. Glasser,et al. Functional characteristics of in vivo induced neutrophils after differentiation therapy of acute promyelocytic leukemia with all‐trans‐retinoic acid , 1994, Cancer.
[547] R. Gallagher. Arsenic--new life for an old potion. , 1998, The New England journal of medicine.
[548] K. Weber,et al. NuMA: a bipartite nuclear location signal and other functional properties of the tail domain. , 1996, Experimental cell research.
[549] S. Minucci,et al. Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo , 1994, Molecular and cellular biology.
[550] R. Cook,et al. Amino acid sequence of protein B23 phosphorylation site. , 1986, The Journal of biological chemistry.
[551] R. Evans,et al. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. , 1992, Genes & development.
[552] V. Notario,et al. Modification of nucleolar protein B23 after exposure to ionizing radiation. , 1995, Radiation research.
[553] K. Umesono,et al. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[554] R. Berger,et al. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. , 1992, Leukemia.
[555] K. Gollahon,et al. Identification of the promoter of the myelomonocytic leukocyte integrin CD11b. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[556] P. Fenaux,et al. Acute promyelocytic leukemia: biology and treatment. , 1997, Seminars in oncology.
[557] Maria Carmo-Fonseca,et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.
[558] R. Traut,et al. Topography and stoichiometry of acidic proteins in large ribosomal subunits from Artemia salina as determined by crosslinking. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[559] H. de Thé,et al. Induction of the PML protein by interferons in normal and APL cells. , 1995, Leukemia.
[560] M. Koken,et al. PML induces a novel caspase-independent death process , 1998, Nature Genetics.
[561] D. Samid,et al. Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate. , 1997, International journal of radiation biology.
[562] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[563] H. Satoh,et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[564] R. Müller,et al. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. , 1994, Journal of cell science.
[565] T. Copeland,et al. Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23. , 1993, The Journal of biological chemistry.
[566] T. Naoe,et al. Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia , 1997, Leukemia.
[567] P. Pandolfi,et al. Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.
[568] K. Borden,et al. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. , 1998, The Biochemical journal.
[569] D. Grimwade,et al. Acute promyelocytic leukaemia with t(11;17)(q23;q12‐21) and a good initial response to prolonged ATRA and combination chemotherapy , 1998, British journal of haematology.